Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jun 21 04:00PM ET
130.72
Dollar change
+1.05
Percentage change
0.81
%
IndexDJIA, S&P 500 P/E145.52 EPS (ttm)0.90 Insider Own0.12% Shs Outstand2.53B Perf Week1.04%
Market Cap331.09B Forward P/E13.20 EPS next Y9.90 Insider Trans-11.88% Shs Float2.53B Perf Month-0.03%
Income2.31B PEG- EPS next Q2.15 Inst Own78.74% Short Float0.81% Perf Quarter5.74%
Sales61.09B P/S5.42 EPS this Y472.24% Inst Trans0.64% Short Ratio2.74 Perf Half Y22.75%
Book/sh15.94 P/B8.20 EPS next Y14.56% ROA2.16% Short Interest20.41M Perf Year17.60%
Cash/sh2.25 P/C57.97 EPS next 5Y- ROE5.29% 52W Range99.14 - 133.10 Perf YTD19.90%
Dividend Est.3.14 (2.40%) P/FCF29.99 EPS past 5Y-42.70% ROI3.22% 52W High-1.79% Beta0.40
Dividend TTM3.04 (2.33%) Quick Ratio0.99 Sales past 5Y7.72% Gross Margin71.63% 52W Low31.85% ATR (14)2.17
Dividend Ex-DateJun 17, 2024 Current Ratio1.25 EPS Y/Y TTM-82.24% Oper. Margin8.23% RSI (14)55.79 Volatility1.60% 1.74%
Employees72000 Debt/Eq0.85 Sales Y/Y TTM7.01% Profit Margin3.77% Recom1.50 Target Price143.49
Option/ShortYes / Yes LT Debt/Eq0.77 EPS Q/Q69.28% Payout2065.60% Rel Volume2.27 Prev Close129.67
Sales Surprise3.75% EPS Surprise9.79% Sales Q/Q8.38% EarningsApr 25 BMO Avg Volume7.46M Price130.72
SMA201.37% SMA501.60% SMA20011.62% Trades Volume16,893,922 Change0.81%
Date Action Analyst Rating Change Price Target Change
Mar-11-24Downgrade Societe Generale Hold → Sell $104
Jan-04-24Upgrade TD Cowen Market Perform → Outperform $125 → $135
Nov-09-23Initiated Deutsche Bank Buy $115
Oct-27-23Upgrade BMO Capital Markets Market Perform → Outperform $132
Oct-20-23Upgrade UBS Neutral → Buy $117 → $122
Jul-14-23Initiated HSBC Securities Hold $123
Apr-13-23Upgrade Citigroup Neutral → Buy $105 → $130
Mar-28-23Downgrade Societe Generale Buy → Hold
Mar-13-23Downgrade Wells Fargo Overweight → Equal Weight $120 → $115
Mar-06-23Initiated Jefferies Buy $125
Jun-21-24 12:14PM
06:36AM
Jun-20-24 10:15AM
10:00AM
Jun-18-24 01:02PM
11:26AM Loading…
11:26AM
10:19AM
08:54AM
08:06AM
Jun-17-24 05:29PM
05:15PM
07:01AM
Jun-13-24 07:38AM
05:59AM
Jun-12-24 05:45PM
12:45PM Loading…
12:45PM
06:00AM
Jun-11-24 05:50PM
04:40PM
11:53AM
10:51AM
10:00AM
07:00AM
Jun-10-24 11:44AM
Jun-07-24 11:36AM
11:35AM
Jun-06-24 11:45AM
07:00AM
Jun-05-24 05:45PM
04:46PM
06:45AM Loading…
06:45AM
Jun-04-24 04:25AM
Jun-03-24 12:27PM
08:00AM
May-31-24 12:21PM
May-30-24 12:24PM
May-29-24 07:35AM
07:15AM
07:05AM
07:02AM
06:45AM
06:25AM
May-28-24 09:26PM
09:04PM
05:45PM
03:12PM
02:04PM
06:47AM
06:45AM
May-27-24 12:54PM
May-25-24 03:01PM
02:53PM
May-24-24 12:16PM
May-23-24 04:03PM
01:40PM
May-22-24 09:50AM
May-20-24 09:14AM
May-17-24 06:00AM
May-16-24 10:51AM
09:35AM
May-15-24 06:45AM
May-14-24 09:25AM
05:21AM
May-13-24 01:09PM
06:45AM
May-10-24 06:30AM
06:01AM
May-09-24 09:00AM
07:05AM
06:45AM
May-08-24 09:15AM
08:30AM
06:56AM
06:45AM
May-07-24 02:49PM
May-06-24 02:30PM
10:50AM
08:11AM
May-03-24 09:50AM
May-02-24 02:53PM
May-01-24 06:52PM
07:15AM
06:24AM
Apr-30-24 08:44AM
Apr-29-24 09:00AM
Apr-28-24 06:54PM
Apr-27-24 09:14AM
Apr-26-24 10:59AM
Apr-25-24 05:54PM
04:09PM
03:30PM
02:29PM
12:52PM
12:09PM
11:42AM
11:34AM
11:23AM
10:54AM
10:30AM
09:13AM
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
DeLuca Richard R.EVP&Pres, Merck Animal HeallthMay 04 '24Option Exercise127.5127,1263,458,836163,720May 06 04:08 PM
Oosthuizen Johannes JacobusPresident, U.S. MarketMay 04 '24Option Exercise127.51912116,28924,271May 06 04:01 PM
Klobuchar Michael AEVP - Chief Strategy OfficerMay 04 '24Option Exercise127.51887113,10124,058May 06 04:06 PM
Smart DaltonSVP Fin. - Global ControllerMay 04 '24Option Exercise127.5161278,0364,730May 06 04:10 PM
Smart DaltonSVP Fin. - Global ControllerMay 03 '24Option Exercise128.262,046262,4204,708May 06 04:10 PM
Romanelli JosephPresident, Human Health Int?lMay 02 '24Option Exercise128.802,262291,34621,831May 02 04:29 PM
Smart DaltonSVP Fin. - Global ControllerMay 02 '24Option Exercise128.8038149,0733,048May 02 04:23 PM
Merck & Co., Inc.10% OwnerMar 11 '24Buy23.0021,397,205492,135,7151,000Mar 11 03:27 PM
Davis Robert MChairman, CEO & PresidentFeb 14 '24Option Exercise73.7385,0216,268,598433,348Feb 15 04:01 PM
Litchfield CarolineEVP & CFOFeb 14 '24Option Exercise58.0838,2912,223,94189,199Feb 15 04:03 PM
Davis Robert MChairman, CEO & PresidentFeb 14 '24Sale125.4085,02110,661,574348,327Feb 15 04:01 PM
Litchfield CarolineEVP & CFOFeb 14 '24Sale125.5038,2914,805,52050,908Feb 15 04:03 PM
Davis Robert MChairman, CEO & PresidentFeb 13 '24Option Exercise74.18150,00011,127,160498,327Feb 15 04:01 PM
Davis Robert MChairman, CEO & PresidentFeb 13 '24Sale125.85150,00018,877,424348,327Feb 15 04:01 PM
Romanelli JosephPresident, Human Health Int?lFeb 13 '24Sale124.891,000124,88819,569Feb 14 04:03 PM
Li Dean YExecutive VP & President, MRLFeb 09 '24Option Exercise62.0714,702912,55360,944Feb 12 04:03 PM
Li Dean YExecutive VP & President, MRLFeb 09 '24Sale125.5014,7021,845,08346,242Feb 12 04:03 PM
Williams David MichaelEVP,Chief Info&Digital OfficerFeb 07 '24Sale127.571,451185,10819,812Feb 08 04:04 PM
MIZELL STEVENEVP, Chief HR OfficerFeb 02 '24Option Exercise73.6532,9942,430,15974,313Feb 02 04:07 PM
Zachary JenniferEVP, General CounselFeb 02 '24Option Exercise87.1019,4171,691,22178,557Feb 02 04:05 PM
Oosthuizen Johannes JacobusPresident, U.S. MarketFeb 02 '24Option Exercise78.8020,9371,649,90642,286Feb 05 04:01 PM
MIZELL STEVENEVP, Chief HR OfficerFeb 02 '24Sale126.6550,6946,420,34923,619Feb 02 04:07 PM
Zachary JenniferEVP, General CounselFeb 02 '24Sale126.9749,4996,284,77929,058Feb 02 04:05 PM
Oosthuizen Johannes JacobusPresident, U.S. MarketFeb 02 '24Sale127.1718,9592,411,11123,327Feb 05 04:01 PM
Oosthuizen Johannes JacobusPresident, U.S. MarketNov 09 '23Sale102.382,081213,06118,191Nov 13 07:36 AM
DeLuca Richard R.EVP&Pres, Merck Animal HeallthNov 08 '23Sale105.0343,8234,602,668111,764Nov 09 09:04 AM
Oosthuizen Johannes JacobusPresident, U.S. MarketOct 30 '23Option Exercise102.8291594,08020,723Oct 31 11:08 AM
MIZELL STEVENEVP, Chief HR OfficerAug 14 '23Sale109.014,250463,29222,935Aug 15 04:08 PM
Guindo ChirfiChief Marketing OfficerAug 03 '23Option Exercise105.7036,9013,900,43638,342Aug 04 04:17 PM
MIZELL STEVENEVP, Chief HR OfficerAug 03 '23Sale105.494,500474,70127,185Aug 04 04:06 PM
Romanelli JosephPresident, Human Health Int?lAug 02 '23Sale107.37596,3350Aug 03 04:08 PM
Romanelli JosephPresident, Human Health Int?lAug 02 '23Sale107.37303,22120,569Aug 03 04:08 PM